taiwan
atherosclerot
cardiovascular
diseas
ascvd
carri
high
morbid
mortal
therefor
major
risk
factor
control
particular
import
patient
ascvd
reduc
recurr
cardiovascular
event
clinic
guidelin
codevelop
taiwan
societi
cardiolog
taiwan
societi
lipid
atherosclerosi
diabet
associ
republ
china
taiwan
li
et
al
assist
health
care
profession
taiwan
control
hypertens
hypercholesterolemia
diabet
mellitu
panel
also
highlight
recommend
blood
pressur
cholesterol
sugar
control
ascvd
medic
benefici
ascvd
xiong
et
al
evalu
efficaci
safeti
tripterygium
wilfordii
hook
f
twhf
diabet
nephropathi
dn
patient
overt
proteinuria
normal
egfr
total
dn
patient
randomli
assign
two
group
receiv
either
valsartan
mgd
treatment
control
group
twhf
mgd
plu
valsartan
mg
treatment
twhf
group
week
primari
endpoint
reduct
urin
protein
excret
baselin
end
studi
secondari
endpoint
observ
chang
estim
glomerular
filtrat
rate
egfr
two
group
treatment
signific
decreas
proteinuria
observ
patient
receiv
twhf
treatment
ae
h
ae
h
compar
valsartan
monotherapi
ae
h
ae
h
percentag
chang
urin
protein
excret
twhf
group
valsartan
group
patient
plasma
albumin
twhf
group
ae
gl
ae
gl
higher
control
group
ae
gl
ae
gl
howev
advers
event
twhf
group
higher
control
group
summari
twhf
effect
valsartan
monotherapi
reduct
proteinuria
dn
patient
overt
proteinuria
normal
egfr
advers
effect
cardiac
manifest
prognost
factor
lateonset
hereditari
transthyretin
amyloidosi
variant
remain
clarifi
end
lai
et
al
retrospect
collect
patient
attr
studi
clinic
profil
echocardiographi
ecg
find
patient
met
criteria
left
ventricular
lv
hypertrophi
reduc
global
longitudin
strain
gl
note
rel
apic
spare
pattern
low
voltag
pattern
ecg
observ
present
pseudoinfarct
pattern
endsystol
lv
inner
dimens
hr
ci
p
z
reduc
gl
hr
p
z
rel
apic
longitudin
strain
ral
hr
p
z
increas
ea
ratio
hr
p
z
increas
qr
durat
hr
p
z
correl
reduc
surviv
univari
analysi
multivari
analysi
reveal
reduc
ral
significantli
correl
reduc
surviv
hr
p
z
thu
attr
cardiomyopathi
well
polyneuropath
syndrom
contemporari
echocardiograph
techniqu
use
identifi
cardiac
amyloidosi
provid
prognost
inform
studi
chang
et
al
assess
accuraci
predict
computeraid
threedimension
simul
navig
orthognath
surgeri
casno
protocol
adult
patient
treat
orthognath
surgeri
adult
patient
skelet
class
iii
malocclus
requir
orthognath
surgeri
enrol
threeavail
onlin
wwwsciencedirectcom
dimension
imag
data
presurg
postsurg
ct
compar
assess
accuraci
casno
plan
accuraci
casno
protocol
evalu
calcul
differ
posit
select
landmark
simul
surgic
postsurg
imag
paramet
includ
anb
anv
pognv
posit
select
landmark
an
point
point
b
pog
chang
horizont
xaxi
vertic
yaxi
direct
overal
geograph
discrep
plan
assess
superimpos
color
map
imag
total
adult
patient
mean
age
ae
year
femalemal
z
enrol
geograph
chang
overal
superimposit
plan
postsurg
imag
ae
mm
rang
mm
discrep
simul
postsurg
anb
anv
pognv
ae
ae
mm
ae
mm
respect
deviat
simul
postsurg
point
point
b
posit
within
mm
horizont
vertic
direct
therefor
applic
predesign
boni
guid
splint
casno
protocol
may
allow
surgeon
treat
patient
craniofaci
deform
precis
resistanceassoci
substitut
mongolian
chronic
hepat
c
patient
ledipasvirsofosbuvir
therapi
hepat
c
viru
hcv
infect
global
health
problem
mongolia
highest
preval
antihcv
world
ledipasvirsofosbuvir
ldvsof
introduc
mongolia
sinc
hcv
erad
hcv
resistanceassoci
substitut
rass
may
affect
effect
ldvsof
western
chronic
hepat
c
chc
patient
collabor
studi
hsu
et
al
investig
effect
ldvsof
impact
ra
treatment
outcom
mongolian
chc
patient
patient
genotyp
gt
hcv
infect
enrol
mongolia
treat
ldvsof
week
proport
pretreat
ra
viral
quasispeci
measur
use
nextgener
sequenc
endpoint
ldvsof
effect
sustain
virolog
respons
posttreat
week
total
chc
patient
evalu
baselin
proport
patient
patient
complet
ldvsof
treatment
svr
rate
rate
failur
achiev
patient
respect
p
trend
z
older
age
baselin
alanin
transaminas
level
uml
higher
proport
associ
treatment
failur
univari
analysi
multivari
analysi
higher
proport
associ
treatment
failur
p
z
summari
ldvsof
therapi
achiev
high
svr
rate
mongolian
chc
patient
without
baselin
ra
howev
higher
proport
may
undermin
effect
wu
et
al
extend
previou
observ
assess
whether
ag
patient
vitamin
defici
patient
significantli
higher
frequenc
anemia
hematin
defici
hyperhomocysteinemia
serum
gastric
pariet
cell
antibodi
gpca
posit
healthi
control
blood
hemoglobin
hb
serum
iron
vitamin
folic
acid
homocystein
gpca
level
patient
healthi
control
subject
measur
compar
result
show
patient
significantli
lower
mean
blood
hb
serum
iron
level
well
significantli
higher
mean
corpuscular
volum
mcv
mean
serum
homocystein
level
healthi
control
subject
pvalu
moreov
patient
significantli
higher
frequenc
macrocytosi
blood
hb
iron
folic
acid
defici
hyperhomocysteinemia
serum
gpca
posit
healthi
control
subject
pvalu
addit
anem
patient
pernici
anemia
pa
macrocyt
anemia
pa
normocyt
anemia
iron
defici
anemia
ida
one
microcyt
anemia
ida
thalassemia
traitinduc
anemia
brief
patient
significantli
higher
frequenc
macrocytosi
blood
hb
iron
folic
acid
defici
hyperhomocysteinemia
serum
gpca
posit
healthi
control
subject
glioblastoma
gbm
highest
fatal
rate
among
primari
malign
brain
tumor
wherea
gbm
synchron
multipl
foci
multipl
gbm
rare
shieh
et
al
retrospect
compar
clinic
characterist
multipl
singl
gbm
identifi
factor
associ
surviv
gbm
evalu
effect
primari
endpoint
overal
surviv
os
independ
factor
surviv
identifi
cox
regress
total
patient
identifi
gbm
gliosarcoma
gsm
preoper
imag
show
patient
multipl
brain
lesion
gsm
show
high
ratio
multipl
lesion
patient
gbm
p
z
multipl
lesion
significantli
wors
median
os
month
compar
patient
singl
lesion
month
p
z
addit
multipl
gbm
predictor
wors
surviv
hazard
ratio
hr
z
confid
interv
ci
adjust
signific
predictor
radiotherapi
hr
z
ci
conclus
patient
multipl
gbm
wors
surviv
compar
singl
gbm
gbm
without
postop
radiotherapi
also
predictor
wors
surviv
substanc
use
disord
sud
associ
borderlin
antisoci
person
disord
et
al
investig
associ
substanc
person
psychosoci
distress
individu
heroin
use
disord
hud
methamphetamin
use
disord
mud
control
group
rural
area
taiwan
use
crosssect
questionnairebas
studi
tridimension
person
questionnair
tpq
opiat
treatment
index
use
assess
associ
person
psychosoci
condit
deviat
three
person
dimens
tpq
novelti
seek
harm
avoid
reward
depend
could
reflect
eight
person
pattern
data
indic
sud
associ
high
novelti
seek
harm
avoid
trait
explos
borderlin
person
pattern
wherea
hud
also
link
sensit
narcissist
pattern
subject
hud
tend
deviant
person
trait
subject
mud
subject
sud
three
person
dimens
sensit
narcissist
person
pattern
associ
emot
somat
distress
explos
borderlin
sensit
narcissist
pattern
poor
social
function
taken
togeth
substanc
abus
high
novelti
seek
harm
avoid
correspond
explos
borderlin
sensit
narcissist
pattern
higher
tendenc
suffer
somat
psychosoci
distress
hepat
c
viru
hcv
infect
second
lead
caus
liverrel
liver
mortal
taiwan
transfus
import
rout
hcv
transmiss
blood
donor
screen
antihcv
earli
therefor
continu
strengthen
safeti
blood
product
import
issu
reduc
risk
transfusiontransmit
hcv
taiwan
highli
sensit
serolog
nat
assay
use
blood
donat
screen
shorten
window
period
hiv
hbv
hcv
infect
sinc
short
report
huang
et
al
total
case
suspect
transfusiontransmit
hcv
infect
analyz
none
bag
donat
blood
posit
hcv
nucleic
acid
eleven
suspect
case
posit
hcv
nucleic
acid
genotyp
data
genotyp
genotyp
genotyp
short
case
acut
hepat
c
ahc
due
transfus
hcv
contamin
blood
product
confirm
taiwan
decemb
outbreak
novel
coronaviru
infect
occur
wuhan
china
spread
mani
citi
within
china
sever
countri
includ
taiwan
februari
confirm
case
coronaviru
diseas
taiwan
issu
cheng
et
al
report
first
confirm
case
novel
coronaviru
pneumonia
ncp
taiwan
case
report
clearli
reveal
natur
cours
ncp
selfrecoveri
may
good
exampl
comparison
medic
treatment
addit
develop
rapid
diagnost
assay
effect
treatment
well
wide
use
chest
ct
remain
key
contain
worldwid
outbreak
infect
futur
